Park Avenue Compounding Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII recall — FDA D-0178-2026
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Overview of recall records associated with Park Avenue Compounding, including dates, categories and classifications where available.
Classification mix: Class II: 1.
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
This page summarizes recall records in which the official source identifies Park Avenue Compounding as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.